Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block
1 other identifier
interventional
56
1 country
1
Brief Summary
to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2017
CompletedFirst Posted
Study publicly available on registry
March 16, 2017
CompletedStudy Start
First participant enrolled
April 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2017
CompletedJanuary 3, 2018
December 1, 2017
8 months
March 12, 2017
December 29, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of hemidiaphragmatic paralysis
incidence of hemidiaphragmatic paralysis by M mode USG to be seen
24 hours
Secondary Outcomes (1)
postoperative pain
24 hours
Study Arms (2)
block
EXPERIMENTALwill be given block and continuous infusion with bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine
control
EXPERIMENTALIV analgesia only with diclofenac and paracetamol
Interventions
bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine
iv diclofenac 75 mg TDS iv paracetamol 1gm TDS
Eligibility Criteria
You may qualify if:
- Patients aged 18-65 years and belonging to ASA grade I, II, III, undergoing either, shoulder surgery, (rotator cuff repair, acromioplasty, hemiarthroplasty, and total shoulder replacement) or surgery for proximal humerus fracture will be recruited for the study.
You may not qualify if:
- a) Patient refusal for interscalene block b) Severe respiratory disease (FEV1/FVC \<0.7 and FEV1 \< 80% of predicted) c) Allergy to amide local anaesthetic drugs d) Chronic opioid therapy e) Patients who cannot understand how to operate PCA and VAS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PGIMER
Chandigarh, 160012, India
Related Publications (3)
Sinha SK, Abrams JH, Barnett JT, Muller JG, Lahiri B, Bernstein BA, Weller RS. Decreasing the local anesthetic volume from 20 to 10 mL for ultrasound-guided interscalene block at the cricoid level does not reduce the incidence of hemidiaphragmatic paresis. Reg Anesth Pain Med. 2011 Jan-Feb;36(1):17-20. doi: 10.1097/aap.0b013e3182030648.
PMID: 21751435BACKGROUNDRenes SH, Rettig HC, Gielen MJ, Wilder-Smith OH, van Geffen GJ. Ultrasound-guided low-dose interscalene brachial plexus block reduces the incidence of hemidiaphragmatic paresis. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):498-502. doi: 10.1097/AAP.0b013e3181b49256.
PMID: 19920426BACKGROUNDFredrickson MJ, Price DJ. Analgesic effectiveness of ropivacaine 0.2% vs 0.4% via an ultrasound-guided C5-6 root/superior trunk perineural ambulatory catheter. Br J Anaesth. 2009 Sep;103(3):434-9. doi: 10.1093/bja/aep195. Epub 2009 Jul 16.
PMID: 19608563BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Junior resident, Department of Anaesthesia and Intensive Care, MD
Study Record Dates
First Submitted
March 12, 2017
First Posted
March 16, 2017
Study Start
April 1, 2017
Primary Completion
November 16, 2017
Study Completion
November 16, 2017
Last Updated
January 3, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share